Medicine information XERMELO 250mg film-coated tablets

Product code:
W72291001
Quantity:
90
Indicated for:
carcinoid syndrome diarrhea
Route of administration:
oral
Substance:
telotristat (enzyme inhibitor)
ATC
A16AX15 — Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products
Telotristat is a tryptophan hydroxylase inhibitor used for the treatment of severe diarrhea associated with carcinoid syndrome. It works by reducing the production of serotonin, a hormone involved in the symptoms of carcinoid syndrome.

The medication is taken orally, usually three times daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular medical check-ups to monitor the response to treatment.

Patients should be aware of potential side effects, such as nausea, abdominal pain, or fatigue. It is important to inform the doctor of any unusual symptoms.

Common side effects include nausea, abdominal pain, fatigue, and decreased appetite. In rare cases, severe reactions such as elevated liver enzymes or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about XERMELO 250mg

Substance:
telotristat
Date of latest medicines list:
01-11-2026
Product code:
W72291001
Strength:
250mg
Pharmaceutical form:
film-coated tablets
Quantity:
90
Product type:
Generic medicine
Price:
12301.44 RON
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
SERB SAS - FRANTA
Holder:
C.N. UNIFARM S.A. - ROMANIA
Number:
1293/2026/01
Shelf life:
5 years